Drug Discovery App CS WP
-
Evaluation Of Influenza Production In MDCK CD Medium
8/29/2022
Learn more about the production benefits imposed using MDCK cells that have the potential to significantly reduce lead times for vaccine production and alleviate constraints on raw material supply.
-
Approaches To Establishing A Perfusion Mimic Process
8/26/2022
We demonstrate how high throughput perfusion mimic processes can be achieved in microbioreactors with good consistency amongst the replicates and with sustained cell viability and protein production.
-
Enabling Early Assessment Of Drug Targets To Maximize Success
8/23/2022
Comprehensive diligence around a target before starting a discovery program can make the difference between success and failure.
-
Successful Wetting For Filter Integrity Testing In Volume-Restricted Systems
8/18/2022
Filters with a qualified retention for bacteria, mycoplasma or viruses are commonly used in many pharmaceutical processes. In a validated GMP process, these filters must be routinely tested for integrity.
-
Harnessing Targeted Protein Degradation
7/28/2022
A leading biotech company working in the targeted protein degradation space was looking for fast delivery of the compounds, open, transparent and on-time communication, and flexibility and ability to scale.
-
Apheresis Variability Control In Cell Therapy Manufacturing
7/25/2022
Explore our best practices for apheresis collection and obtention of enriched product for cell therapies.
-
Automating And Optimizing The Cell Harvesting Process
7/25/2022
Discover how we automate the process of optimizing cell harvesting and further minimize the potential for cell loss during wash steps.
-
Natural Killer Cells Manufacturing
7/22/2022
Follow the feasibility of xeno‑free NK cell expansion, closure of key unit operations, and how future work could focus on fine‑tuning each step to generate a robust, scalable process.
-
Optimizing Recovery On The Sepax™ Cell Processing System
7/21/2022
Using a model T-cell line, we demonstrate the impact of varying rinse volume, intermediate volume, and manual extraction parameters on overall cell recovery with a final product dose volume of 20 mL.
-
Systems Employ New Single-Pass TFF Technology To Simplify Processes And Lower Costs
7/20/2022
Single-pass TFF technology brings practical and economic advances to TFF by simplifying the process and creating new capabilities.